Your Trusted Source for Canadian News and Insights

Immigration

Your Trusted Source for Canadian News and Insights
HomeImmigration

All News

TCTM Announces the Appointments of Mr. Heng Wang as Chief Executive Officer and Mr. Robert L. Angell as Chief Technology Officer

BEIJING,March 4,2025-- TCTM Kids IT Education Inc. (NASDAQ: TCTM) ("TCTM" or the "Company"),a leading provider of IT-focused supplementary STEM education services in China,today an

Mar 5, 2025
Immigration

Investor Webinar: Telix Therapeutics Urology Showcase and Expert Forum

MELBOURNE,Australia and INDIANAPOLIS,Ind.,March 4,2025-- Telix Pharmaceuticals Limited (ASX: TLX,Nasdaq: TLX,Telix,the Company) invites investors to join a webinar showcasing the Company\'s late-stag

Mar 5, 2025
Immigration

ITU and Huawei Jointly Release the White Paper on Lithium Batteries for Telecom Sites

BARCELONA,Spain,March 4,2025-- Huawei Global Digital Power Summit was held at MWC 2025 with the theme of "AI Powering a Greener ICT." Operators,leading enterprises,industry leaders,and indus

Mar 5, 2025
Immigration

Huawei Li Peng: Maximizing 5G Network Value in the Age of AI

BARCELONA,Spain,March 4,2025-- At MWC Barcelona 2025,Li Peng,Huawei\'s Corporate Senior Vice President and President of ICT Sales & Service,delivered a keynote on how carriers can make the most of

Mar 5, 2025
Immigration

Look Out McDonald's And KFC: Here Comes China's Alan Song

HONG KONG,March 4,2025-- China\'s largest restaurant chains aren\'t as well-known globally as McDonald\'s andKFC. Yet one of the country\'s most successful venture capitalists thinks their internation

Mar 5, 2025
Immigration

Celltrion receives U.S. FDA approval for STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) biosimilars referencing PROLIA® and XGEVA®

STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) are approved by FDA for all indications of reference products PROLIA® (denosumab) and XGEVA® (denosumab) respectively[1],[2]

Mar 5, 2025
Immigration
1 ... 51 52 53 54 55 56 57 ... 112